SRGAP1
Basic information
Region (hg38): 12:63843761-64162217
Links
Phenotypes
GenCC
Source:
- thyroid cancer, nonmedullary, 2 (No Known Disease Relationship), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRGAP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 18 | ||||
missense | 48 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 6 | 1 | 7 | |||
non coding | 3 | |||||
Total | 0 | 0 | 50 | 15 | 10 |
Variants in SRGAP1
This is a list of pathogenic ClinVar variants found in the SRGAP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-63844821-C-A | SRGAP1-related disorder | Uncertain significance (Jul 03, 2024) | ||
12-63844892-G-A | Likely benign (Apr 09, 2018) | |||
12-63984024-C-T | Benign/Likely benign (Jun 01, 2022) | |||
12-63984040-G-A | SRGAP1-related disorder | Uncertain significance (Oct 23, 2023) | ||
12-63984061-C-T | Thyroid cancer, nonmedullary, 2 • not specified | Uncertain significance (Mar 04, 2024) | ||
12-63984062-G-A | Likely benign (Jun 08, 2018) | |||
12-63984086-G-C | not specified | Uncertain significance (Nov 30, 2022) | ||
12-63984101-C-A | not specified | Uncertain significance (Dec 16, 2023) | ||
12-64016946-A-T | SRGAP1-related disorder | Likely benign (Apr 08, 2019) | ||
12-64016970-A-C | Thyroid cancer, nonmedullary, 2 | Pathogenic (May 01, 2013) | ||
12-64016975-A-T | not specified | Uncertain significance (Oct 10, 2023) | ||
12-64017011-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
12-64042855-C-T | SRGAP1-related disorder | Likely benign (Mar 02, 2021) | ||
12-64042931-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
12-64043443-C-G | Benign (Dec 31, 2019) | |||
12-64043493-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
12-64043505-T-TAG | Thyroid cancer, nonmedullary, 2 | Uncertain significance (Feb 19, 2020) | ||
12-64043534-G-A | Uncertain significance (Aug 01, 2022) | |||
12-64043573-G-T | SRGAP1-related disorder | Uncertain significance (Apr 28, 2024) | ||
12-64062920-TG-GT | SRGAP1-related disorder | Uncertain significance (Nov 17, 2022) | ||
12-64062921-G-A | Congenital anomaly of kidney and urinary tract • Nephronophthisis | Uncertain significance (May 28, 2020) | ||
12-64062938-G-A | Thyroid cancer, nonmedullary, 2 | Pathogenic (May 01, 2013) | ||
12-64062966-A-G | not specified | Uncertain significance (Aug 02, 2023) | ||
12-64063051-G-A | SRGAP1-related disorder | Likely benign (Jul 18, 2024) | ||
12-64063055-G-A | not specified | Uncertain significance (Mar 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SRGAP1 | protein_coding | protein_coding | ENST00000355086 | 22 | 303541 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00155 | 125729 | 0 | 17 | 125746 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.21 | 454 | 607 | 0.748 | 0.0000330 | 7204 |
Missense in Polyphen | 90 | 150.86 | 0.59656 | 1767 | ||
Synonymous | 1.39 | 202 | 229 | 0.883 | 0.0000130 | 2019 |
Loss of Function | 5.81 | 8 | 54.1 | 0.148 | 0.00000293 | 654 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000120 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000719 | 0.0000703 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000131 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42. {ECO:0000269|PubMed:11672528}.;
- Disease
- DISEASE: Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms. {ECO:0000269|PubMed:23539728}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;Signal Transduction;Rho GTPase cycle;Inactivation of CDC42 and RAC1;Signaling by Rho GTPases;Signaling by ROBO receptors;Axon guidance;Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.610
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 12.01
Haploinsufficiency Scores
- pHI
- 0.370
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.548
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.503
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Srgap1
- Phenotype
Gene ontology
- Biological process
- signal transduction;negative regulation of cell migration;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction
- Cellular component
- cytoplasm;cytosol
- Molecular function
- GTPase activator activity;protein binding;Rac GTPase binding